Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium Alessandro Nini, Umberto Capitanio, Alessandro Larcher, Paolo Dell’Oglio, Federico Dehò, Nazareno Suardi, Fabio Muttin, Cristina Carenzi, Massimo Freschi, Roberta Lucianò, Giovanni La Croce, Alberto Briganti, Renzo Colombo, Andrea Salonia, Alessandro Castiglioni, Patrizio Rigatti, Francesco Montorsi, Roberto Bertini European Urology DOI: 10.1016/j.eururo.2017.08.019 Copyright © 2017 European Association of Urology Terms and Conditions
Fig. 1 Overall survival rate in 46 patients treated with radical nephrectomy and caval thrombectomy with extracorporeal circulation and deep hypothermic circulatory arrest. C.E=cumulative event rates; N.R=number at risk. European Urology DOI: (10.1016/j.eururo.2017.08.019) Copyright © 2017 European Association of Urology Terms and Conditions
Fig. 2 Cancer specific mortality free survival rate in 46 patients treated with radical nephrectomy and caval thrombectomy with extracorporeal circulation and deep hypothermic circulatory arrest. C.E=cumulative event rates; N.R=number at risk. European Urology DOI: (10.1016/j.eururo.2017.08.019) Copyright © 2017 European Association of Urology Terms and Conditions
Fig. 3 Overall survival rate in 46 patients treated with radical nephrectomy and caval thrombectomy with extracorporeal circulation and deep hypothermic circulatory arrest according to metastatic status (cM0 vs cM1, p<0.01). Blue line: cM0. Orange line: cM1. C.E=cumulative event rates; N.R=number at risk. European Urology DOI: (10.1016/j.eururo.2017.08.019) Copyright © 2017 European Association of Urology Terms and Conditions
Fig. 4 Cancer specific mortality free survival rate in 46 patients treated with radical nephrectomy and caval thrombectomy with extracorporeal circulation and deep hypothermic circulatory arrest according to metastatic status (cM0 vs cM1, p<0.01). Blue line: cM0. Orange line: cM1. C.E=cumulative event rates; N.R=number at risk. European Urology DOI: (10.1016/j.eururo.2017.08.019) Copyright © 2017 European Association of Urology Terms and Conditions